HighVista Strategies »

Celcuity shares owned by HighVista Strategies

Quarter-by-quarter ownership of Celcuity (CELC) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Celcuity

Tip: Access up to 7 years of quarterly data

All positions including Celcuity held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celcuity by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2025-09-30 $676k 14k 49.40

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Abivax Sa Sponsored Ads (ABVX)
Merus N V (MRUS)
Miragen Therapeutics (VRDN)
Revolution Medicines (RVMD)
Protagonist Therapeutics (PTGX)
Nuvalent Inc-a (NUVL)
Mineralys Therapeutics (MLYS)
Arcellx Common Stock (ACLX)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Insmed Com Par $.01 (INSM)
Cidara Therapeutics Com New (CDTX)
Cogent Biosciences (COGT)
Structure Therapeutics Sponsored Ads (GPCR)

View all positions for HighVista Strategies

Top funds holding Celcuity

Baker Bros. Advisors
Perceptive Advisors
BlackRock
NEA Management Company
Vanguard Group
Soleus Capital Management
Tang Capital Management
Eventide Asset Management
UBS Group
Sio Capital Management
Morgan Stanley
Apis Capital Advisors
Geode Capital Management
Deerfield Management Company
State Street Corporation

View all funds holding Celcuity